HEMOXIN Trademark

Trademark Overview

On Friday, August 16, 2013, a trademark application was filed for HEMOXIN with the United States Patent and Trademark Office. The USPTO has given the HEMOXIN trademark a serial number of 86040698. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 4, 2016. The HEMOXIN trademark is filed in the Pharmaceutical Products category with the following description:

Nutraceutical preparations for treating and conducting medical research in the field of sickle cell disease
hemoxin

General Information

Serial Number86040698
Word MarkHEMOXIN
Filing DateFriday, August 16, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 4, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 7, 2014

Trademark Statements

Goods and ServicesNutraceutical preparations for treating and conducting medical research in the field of sickle cell disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 26, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressHighland Park, NJ 08904
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressHighland Park, NJ 08904

Trademark Events

Event DateEvent Description
Monday, April 4, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 4, 2016ABANDONMENT - NO USE STATEMENT FILED
Thursday, October 8, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 7, 2015EXTENSION 3 GRANTED
Friday, September 4, 2015EXTENSION 3 FILED
Monday, October 5, 2015NOTICE OF REVIVAL - E-MAILED
Monday, October 5, 2015EXTENSION RECEIVED WITH TEAS PETITION
Monday, October 5, 2015PETITION TO REVIVE-GRANTED
Monday, October 5, 2015TEAS PETITION TO REVIVE RECEIVED
Monday, October 5, 2015ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 12, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 11, 2015EXTENSION 2 GRANTED
Tuesday, March 3, 2015EXTENSION 2 FILED
Tuesday, March 3, 2015TEAS EXTENSION RECEIVED
Friday, September 19, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 18, 2014EXTENSION 1 GRANTED
Wednesday, September 3, 2014EXTENSION 1 FILED
Wednesday, September 17, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 3, 2014TEAS EXTENSION RECEIVED
Tuesday, March 4, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 7, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 7, 2014PUBLISHED FOR OPPOSITION
Wednesday, December 18, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 3, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 3, 2013ASSIGNED TO EXAMINER
Monday, August 26, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 20, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

hemoxin field sickle cell disease research medical preparations treating conducting nutraceutical